Search Results

There are 5304 results for: content related to: Empowering Students to Create and Claim Value through the Thomas–Kilmann Conflict Mode Instrument

  1. You have full text access to this OnlineOpen article
    Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

    Thoracic Cancer

    Xiaojuan Qiao, Ye Zhang, Jinghui Wang, Jingying Nong, Xi Li, Xinjie Yang, Jialin Lv, Hui Zhang, Na Qin, Quan Zhang, Wentao Yue and Shucai Zhang

    Article first published online : 12 FEB 2015, DOI: 10.1111/1759-7714.12236

  2. You have free access to this content
    Do we need more drugs for chronic myeloid leukemia?

    Immunological Reviews

    Volume 263, Issue 1, January 2015, Pages: 106–123, Tessa L. Holyoake and G. Vignir Helgason

    Article first published online : 15 DEC 2014, DOI: 10.1111/imr.12234

  3. You have free access to this content
    Structural basis for dual inhibitory role of tamarind Kunitz inhibitor (TKI) against factor Xa and trypsin

    FEBS Journal

    Volume 279, Issue 24, December 2012, Pages: 4547–4564, Dipak N. Patil, Anshul Chaudhary, Ashwani K. Sharma, Shailly Tomar and Pravindra Kumar

    Article first published online : 22 NOV 2012, DOI: 10.1111/febs.12042

  4. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Article first published online : 10 OCT 2014, DOI: 10.1002/jps.24113

  5. You have free access to this content
    Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma

    Cancer

    Volume 117, Issue 21, 1 November 2011, Pages: 4958–4965, Jonathan Verma, Eric Jonasch, Pamela Allen, Nizar Tannir and Anita Mahajan

    Article first published online : 11 APR 2011, DOI: 10.1002/cncr.26138

  6. You have free access to this content
    Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3571–3578, Ryan S. Turley, Peter D. Peng, Srinevas K. Reddy, Andrew S. Barbas, David A. Geller, J. Wallis Marsh, Allan Tsung, Timothy M. Pawlik and Bryan M. Clary

    Article first published online : 15 NOV 2011, DOI: 10.1002/cncr.26650

  7. You have free access to this content
    Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor

    Cancer

    Volume 119, Issue 24, 15 December 2013, Pages: 4325–4332, Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Jumpei Takeshita, Kosuke Tanaka, Shigeki Nanjo, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Kazuya Monden, Takeshi Matsumoto, Kazuma Nagata, Kyoko Otsuka, Ryo Tachikawa, Keisuke Tomii, Kei Kunimasa, Masahiro Iwasaku, Akihiro Nishiyama, Tadashi Ishida and Yoshihiro Nishimura

    Article first published online : 16 SEP 2013, DOI: 10.1002/cncr.28364

  8. Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 242–249, Harry P. Erba

    Article first published online : 30 JAN 2015, DOI: 10.1002/ajh.23902

  9. You have free access to this content
    Targeting survival pathways in chronic myeloid leukaemia stem cells

    British Journal of Pharmacology

    Volume 169, Issue 8, August 2013, Pages: 1693–1707, A Sinclair, A L Latif and T L Holyoake

    Article first published online : 26 JUL 2013, DOI: 10.1111/bph.12183

  10. You have free access to this content
    Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

    International Journal of Cancer

    Volume 131, Issue 5, 1 September 2012, Pages: E822–E829, Guanghui Gao, Shengxiang Ren, Aiwu Li, Jianfang Xu, Qinghua Xu, Chunxia Su, Jian Guo, Qinfang Deng and Caicun Zhou

    Article first published online : 27 JAN 2012, DOI: 10.1002/ijc.27396

  11. Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism

    Histopathology

    Volume 64, Issue 4, March 2014, Pages: 484–493, Toyonori Tsuzuki, Naoto Sassa, Yoshie Shimoyama, Takamitsu Morikawa, Ryoichi Shiroki, Makoto Kuroda, Akitoshi Fukatsu, Kyoko Kuwahara, Yasushi Yoshino, Ryohei Hattori and Momokazu Gotoh

    Article first published online : 26 NOV 2013, DOI: 10.1111/his.12277

  12. Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

    BJU International

    Volume 108, Issue 8b, October 2011, Pages: E250–E257, Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, Roberto Sabbatini, Alessandra Bearz, Isabella Chiappino, Enzo Maria Ruggeri, Giovanni Lo Re, Riccardo Ricotta, Fable Zustovich, Lorenza Landi, Anna Calcagno, Ilaria Imarisio, Elena Verzoni, Mimma Rizzo, Chiara Paglino, Valentina Guadalupi and Emilio Bajetta

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10186.x

  13. Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome

    Journal of Applied Toxicology

    Volume 32, Issue 12, December 2012, Pages: 945–951, Baichun Yang and Thomas Papoian

    Article first published online : 10 SEP 2012, DOI: 10.1002/jat.2813

  14. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour

    ANZ Journal of Surgery

    Volume 84, Issue 12, December 2014, Pages: E1–E8, Ferdinando C. M. Cananzi, Ajay P. Belgaumkar, Bruno Lorenzi and Satvinder Mudan

    Article first published online : 6 MAY 2013, DOI: 10.1111/ans.12195

  15. You have free access to this content
    Evidence for activation of the tissue kallikrein-kinin system in nociceptive transmission and inflammatory responses of mice using a specific enzyme inhibitor

    British Journal of Pharmacology

    Volume 130, Issue 5, July 2000, Pages: 1099–1107, José A da S Emim, Caden Souccar, Maria S de A Castro, Rosely O Godinho, Maria H S Cezari, Luiz Juliano and Antonio J Lapa

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703362

  16. You have full text access to this Open Access content
    Epidermal growth factor receptor mutation-guided treatment for lung cancers: Where are we now?

    Thoracic Cancer

    Volume 2, Issue 1, February 2011, Pages: 1–6, Zengliu Su

    Article first published online : 1 FEB 2011, DOI: 10.1111/j.1759-7714.2010.00035.x

  17. You have full text access to this Open Access content
    Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells

    Cancer Science

    Volume 101, Issue 7, July 2010, Pages: 1577–1581, Kazuhito Naka, Takayuki Hoshii and Atsushi Hirao

    Article first published online : 5 APR 2010, DOI: 10.1111/j.1349-7006.2010.01584.x

  18. Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

    Journal of Cellular Physiology

    Volume 226, Issue 9, September 2011, Pages: 2316–2328, Mary E. Irwin, Kelly L. Mueller, Natacha Bohin, Yubin Ge and Julie L. Boerner

    Article first published online : 9 JUN 2011, DOI: 10.1002/jcp.22570

  19. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics

    PROTEOMICS

    Volume 15, Issue 2-3, January 2015, Pages: 340–355, Xu Zhang, Natalya Belkina, Harrys Kishore Charles Jacob, Tapan Maity, Romi Biswas, Abhilash Venugopalan, Patrick G. Shaw, Min-Sik Kim, Raghothama Chaerkady, Akhilesh Pandey and Udayan Guha

    Article first published online : 15 JAN 2015, DOI: 10.1002/pmic.201400315

  20. You have free access to this content
    Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR–ABL kinase inhibition

    American Journal of Hematology

    Volume 88, Issue 5, May 2013, Pages: 385–393, Pavel Simara, Stanislav Stejskal, Irena Koutna, David Potesil, Lenka Tesarova, Michaela Potesilova, Zbynek Zdrahal and Jiri Mayer

    Article first published online : 27 MAR 2013, DOI: 10.1002/ajh.23419